Cytonus Therapeutics

[Not Yet Scheduled]
Cytonus is reinventing drug-discovery and drug-delivery by questioning the principled approaches of pharmacodynamics (physiological effects of drugs) that has failed patients since the start of medicine. With a revolutionary platform technology called the Cargocyte, Cytonus believe the days of flooding the body with medicines with a hope and prayer to effect disease without overshooting toxicity is not only antiquated, it is scientifically flawed. With a combination of precision drug-delivery and in-vivo drug production the Cargocyte platform enables science and medicines to new level of effectiveness without compromising safety for patients.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
CA-IL-12
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
Cytonus Therapeutics, Inc.